Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Collegium Pharmaceutical, Inc. (COLL) had Debt to Equity Ratio of 3.57 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$177.76M |
|
$2.42M |
|
$80.43M |
|
$97.32M |
|
$156.07M |
|
$21.69M |
|
$-18.57M |
|
$3.12M |
|
$3.12M |
|
$2.42M |
|
$2.42M |
|
$2.42M |
|
$2.42M |
|
$21.69M |
|
$77.93M |
|
31.79M |
|
32.84M |
|
$0.08 |
|
$0.07 |
|
| Balance Sheet Financials | |
$527.55M |
|
$13.85M |
|
$1.10B |
|
$1.63B |
|
$486.71M |
|
$773.13M |
|
$910.24M |
|
$1.40B |
|
$234.43M |
|
$-752.26M |
|
$234.43M |
|
32.13M |
|
| Cash Flow Statement Financials | |
$55.40M |
|
$-9.68M |
|
$-25.24M |
|
$96.61M |
|
$117.09M |
|
$20.48M |
|
$11.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
0.77 |
|
|
Debt to Equity Ratio |
3.57 |
54.75% |
|
12.20% |
|
12.20% |
|
-- |
|
1.76% |
|
1.36% |
|
$54.60M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
2.16 |
|
0.78 |
|
115.80 |
|
1.03% |
|
-0.32% |
|
0.15% |
|
0.24% |
|
$7.30 |
|
$1.66 |
|
$1.69 |
|